chevron_leftBack
As of 24 June 2026, Epi Biotech Co., Ltd. has a market cap of $20.26M USD, ranking #36979 globally and #2328 in South Korea.
It ranks #3318 in the Healthcare sector, and #646 in the Biotechnology industry.
Key Stats
Market Cap
$20.26MUSD
31.14B KRW
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 7.3% | 7.3% | -3.5% | 3.4% | -0.8% | 45% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
446440
주식회사 에피바이오텍
ISIN: KR7446440000
Shares Out.:
Shares Outstanding:
2.307M1
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
14,480 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 207940
|
$44.36B
219K%
68.19T KRW
|
35.5
|
|
KRX: 068270
|
$27.82B
137K%
42.76T KRW
|
43.8
|
|
KRX: 196170
|
$13.23B
65K%
20.33T KRW
|
146.6
|
|
KRX: 028300
|
$5.45B
27K%
8.37T KRW
|
-
|
|
KRX: 087010
|
$3.95B
19K%
6.07T KRW
|
-
|
|
KRX: 302440
|
$2.23B
11K%
3.42T KRW
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: AMGN
|
$182.42B
900K%
|
23.9
|
|
NASDAQ: GILD
|
$159.92B
789K%
|
19.0
|
|
EBR: ARGX
|
$47.29B
233K%
41.39B EUR
|
39.9
|
|
ASX: CSL
|
$42.19B
208K%
60.27B AUD
|
29.3
|
|
SIX: LONN
|
$41.67B
206K%
33.71B CHF
|
37.2
|
|
NASDAQ: NTRA
|
$27.6B
136K%
|
-
|
chevron_leftBack